Publication
Phase 1 Dose Escalation Study of the Allosteric AKT Inhibitor BAY 1125976 in Advanced Solid Cancer-Lack of Association between Activating AKT Mutation and AKT Inhibition-Derived Efficacy
Journal Paper/Review - Dec 10, 2019
Schneeweiss Andreas, Lagkadinou Eleni, Wilkinson Gary, Boix Oliver, Thiele Silke, Rudolph Marion, Rentzsch Christine, Hurvitz Sara A, Ma Cynthia, Tsimberidou Apostolia M, Moulder Stacy, Varga Andrea, Jörger Markus, Hess Dagmar, Ocker Matthias
Schneeweiss, Andreas
77
0
Hess, Dagmar
Medizinische Onkologie und Hämatologie · Dept. I
26
17
Jörger, Markus
chief of serviceMedizinische Onkologie und Hämatologie · Dept. I
175
42
Varga, Andrea
1
0
Moulder, Stacy
1
0
Tsimberidou, Apostolia M
1
0
Ma, Cynthia
1
0
Hurvitz, Sara A
1
0
Rentzsch, Christine
1
0
Rudolph, Marion
1
0
Thiele, Silke
1
0
Boix, Oliver
2
0
Wilkinson, Gary
1
0
Lagkadinou, Eleni
1
0
Ocker, Matthias
2
0